HLA healthia limited
Add to My Watchlist 0.00% ! $1.80

Cannacord updated research - target price $1.45

  1. Dingus21
    380 Posts.
    lightbulb Created with Sketch. 16
    clock Created with Sketch.
    30/07/19
    11:39
    Post #: 39757105
    Updated research emailed to shareholders.

    FY19: EBITDA - $9.6m, EPS (post minorities) $0.07
    FY20: EBITDA - $14.5m, EPS (post minorities) $0.097
    FY21: EBITDA - $18.1m, EPS (post minorities) $0.123
    HLA Price at posting: $1.10 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.